> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Balyasny Reports A 5.21% Passive Position In Tandem Diabetes Care
- URL: https://www.bullished.co/balyasny-reports-a-5-21-passive-position-in-tandem-diabetes-care-fe99ae0f/
- Published: 2026-11-16T11:41:11.000Z
- Updated: 2026-11-16T11:41:11.000Z
- Description: Atlas Diversified Master Fund directly owns the shares, while Tandem plans U.S. and Canadian product additions in 2027.
- Author: Matteo Parrino
- Tags: SEC Filings, TNDM, Industry: Healthcare

Balyasny Asset Management, an investment manager, reported a [5.21% passive position](https://www.sec.gov/Archives/edgar/data/0001218710/000117266126005059/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) in [Tandem Diabetes Care](https://www.bullished.co/tag/tndm/), which designs and sells insulin pumps and related software, in an SEC ownership disclosure filed Monday. The position comprised 3,624,727 common shares as of September 30, directly held by its investment-management client Atlas Diversified Master Fund.

## Atlas Owns The Shares

Atlas has the right to collect dividends and proceeds from sales of the shares. Balyasny Asset Management may be treated as their beneficial owner because its role as investment manager gives it voting and investment authority over the fund's holding.

The reporting parties [certified a passive holding](https://www.sec.gov/Archives/edgar/data/0001218710/000117266126005059/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co): they bought and hold the stock through ordinary business activity, without seeking to change or influence Tandem's control.

The approximately 5.21% figure uses 69,578,707 outstanding common shares as of August 3, 2026, cited from Tandem's quarterly report filed August 6, 2026.

## Mobi Gets A Tubeless Option

Tandem announced [FDA clearance Friday](https://markets.ft.com/data/announce/detail?dockey=600-202611130830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW487071-1&ref=bullished.co) for a cartridge and infusion set that let patients use Mobi without tubing. Patients with existing Mobi pumps can use the accessories without replacing their pumps.

Mobi and Tandem's t:slim X2 pumps connect with continuous glucose monitoring sensors. The company's Control-IQ+ algorithm automatically adjusts insulin dosing. Tandem also sells disposable cartridges and infusion sets, alongside its Tandem Source data platform and Sugarmate app.

San Diego, California, is where pumps are assembled for the business, which serves nearly 500,000 people across more than 25 countries.

## Canada Widens Pump Use

Abbott's FreeStyle Libre 3 Plus sensor can work with the pump under the [Canadian pump approvals](https://markets.ft.com/data/announce/detail?dockey=600-202611120830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW868686-1&ref=bullished.co) detailed in Tandem's Thursday announcement. Expanded indications cover adults with type 2 diabetes and pregnancy among people with type 1 diabetes.

Tandem uses its own sales and support teams in the United States and Canada, with independent distributors fulfilling orders. Outside those markets it has mainly relied on distributors and began direct sales in 2026\. Two distributors each generated more than 10% of worldwide sales in 2025.

Tandem plans to launch tubeless Mobi in the United States in the [first half of 2027](https://markets.ft.com/data/announce/detail?dockey=600-202611130830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW487071-1&ref=bullished.co). It expects the Canadian additions in the [second quarter of 2027](https://markets.ft.com/data/announce/detail?dockey=600-202611120830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW868686-1&ref=bullished.co).

Learn

- [What a Reverse Termination Fee Means: Who Pays When a Merger Collapses →](https://www.bullished.co/learn/reverse-termination-fee-meaning/)  
A reverse termination fee is paid by the buyer to the target if a merger fails on agreed terms. See how it differs from a break-up fee, with live deal examples.
- [How To Read A Merger Proxy: A Checklist For Shareholders Facing A Vote →](https://www.bullished.co/learn/merger-proxy-statement-how-to-read/)  
Facing a merger vote? Read the proxy in this order: price and payment, vote date and threshold, board background, synergy claims, then closing conditions.

### Sources

- [SCHEDULE 13G — BALYASNY ASSET MANAGEMENT L.P. re: Tandem Diabetes Care, Inc. (TNDM)](https://www.sec.gov/Archives/edgar/data/0001218710/000117266126005059/xslSCHEDULE%5F13G%5FX01/primary%5Fdoc.xml?ref=bullished.co) — SEC EDGAR
- [Tandem Mobi Now FDA Cleared as World's First and Only Tubeless AID System with up to Seven Days of Wear – Company Announcement - FT.com](https://markets.ft.com/data/announce/detail?dockey=600-202611130830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW487071-1&ref=bullished.co) — Financial Times
- [Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump – Company Announcement - FT.com](https://markets.ft.com/data/announce/detail?dockey=600-202611120830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW868686-1&ref=bullished.co) — Financial Times
- [Can Tandem Diabetes Care (TNDM) Stay Cheap After Its Recall?](https://finance.yahoo.com/markets/stocks/articles/tandem-diabetes-care-tndm-stay-091008899.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance

### More on Tandem Diabetes Care

- [Tandem Gets FDA Clearance For Tubeless Mobi — Users Can Keep Their Existing Pumps](https://www.bullished.co/tandem-gets-fda-clearance-for-tubeless-mobi-users-can-keep-their-existing-pumps-fd77c650/)
- [Goldman Sachs Reports A 5.9% Passive Stake In Tandem Diabetes Care](https://www.bullished.co/goldman-sachs-reports-a-5-9-passive-stake-in-tandem-diabetes-care-8ee29edd/)
- [Tandem Diabetes Care Nears Operating Break-Even — But U.S. Pump Sales Fall 2%](https://www.bullished.co/tandem-diabetes-care-nears-operating-break-even-but-u-s-pump-sales-fall-2-5104e5a2/)

[All Tandem Diabetes Care (TNDM) coverage →](https://www.bullished.co/tag/tndm/)